1Alatrakchi N,Koziel MJ.Antiviral T-cell responses and therapy in chronic hepatitis B[J].Hepatol,2003,39(4):631-634.
2Lavanchy D.Hepatitis B virus epidemiology,disease burden,treatment,and current and emerging prevention and control measures[J].Viral Hepat,2004,11(2):97-107.
3Kao JH,Chen DS.Global control of hepatitis B virus infection[J].Lancet Infect Dis,2002,2(7):395-403.
4骆抗先.乙型肝炎基础和临床[M]第2版[M].北京：人民卫生出版社,2001.43-70.
5Jung MC,Pape GR.Immunology of hepatitis B infection[J].Lancet Infect Dis,2002,2(1):43-50.
10Ostrowski SR,Gerstoft J,Pedersen BK,et al.A low level of CD4+ CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients[J].Infect Dis,2003,187(11):1726-1734.
2[1]Fei G Z,Sylvan S P,Yao G B,et al. Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon- alpha therapy in patients with chronic hep- atitis B.J Viral Hepat,1999;6:219.
3[5]Maini M K,Boni C,Lee C K, et al. The role of virus- specific CD cells in liver damage and viral control during persistent hepatitis B virus infections. J Exp Med,2000;191:1269.
4[6]Guidettl L G,Rochford R,chung J, et al. Viral clearance without de- struction of infected cells during acute HBV infection.Science,1999; 284:825.
5Nagafuchi S, Kashiwagi S, Hayashi S, et al. Deiayed type hypersonsitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepalitis. Clin Exp Immunol, 1985, 61(3): 569-576
6骆抗先.乙型肝炎基础和临床（第2版）[M].北京:人民卫生出版社,2001.415-435.
7Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol, 1995,13:29-36.
8Ferrari C, Penna A, DegliAntoni A, et al. Cellular immune response to hepatitis B virus antigens. J Hepatol, 1988,7:21-33.
9Leung NW, Tam JS, Lau GT, et al. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases. Cancer, 1994,15:1143-1148.
10Bertoletti A, Ferrari C, Fiaccadori F, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A, 1991, 88:10445-10449.
